Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity

Georgina A Holloway, William Neil Charman, Alan H Fairlamb, Reto Brun, Marcel Kaiser, Edmund Stanley Kostewicz, Patrizia M Novello, John P Parisot, John Richardson, Ian Philip Street, Keith Geoffrey Watson, Jonathan B Baell

Research output: Contribution to journalArticleResearchpeer-review

67 Citations (Scopus)


High-throughput screening of 100,000 lead-like compounds led to the identification of nine novel chemical classes of trypanothione reductase (TR) inhibitors worthy of further investigation. Hits from five of these chemical classes have been developed further through different combinations of preliminary structure-activity relationship rate probing and assessment of antiparasitic activity, cytoxicity, and chemical and in vitro metabolic properties. This has led to the identification of novel TR inhibitor chemotypes that are drug-like and display antiparasitic activity. This paper explores the process of identifying, investigating, and evaluating a series of hits from a high-throughput screening campaign.
Original languageEnglish
Pages (from-to)2824 - 2833
Number of pages10
JournalAntimicrobial Agents and Chemotherapy
Issue number7
Publication statusPublished - 2009

Cite this